Gerlinde Wernig

Gerlinde Wernig, M.D. is an Associate Professor of Pathology at Stanford University and a world expert on fibrosis and blood cancers. She co-discovered the JAK2 V617F mutation that drives myeloproliferative neoplasms and identified c-JUN as a key regulator of fibrosis across organs. Her laboratory develops advanced models of human fibrotic disease, using patient-derived organoids, xenografts, and mouse systems to uncover how inflammation and cancer signaling reshape tissues. By combining next-generation single-cell and multi-omics approaches, Dr. Wernig’s research identifies new targets to treat fibrosis and bone-marrow failure. As a clinical hematopathologist, she brings deep diagnostic expertise to bridge scientific discovery and patient care.